December 5, 2022
SonoThera Raises $61 Million To Advance Ultrasound-Guided, Nonviral Gene Therapy Platform
Read More
December 5, 2022
MaxCyte Signs Strategic Platform License with Curamys to Enable Cell and Gene Therapies
Read More
December 5, 2022
Ideaya Receives Fast Track Designation for Darovasertib with Crizotinib to Treat Rare Eye Melanoma
Read More
December 5, 2022
FDA Lifts Clinical Hold on Beam’s Experimental Gene Editing to Treat Certain T-Cell Cancers
Read More
December 5, 2022
J&J Says It Won’t Make a Bid for Horizon
Read More
December 5, 2022
FDA Grants Breakthrough Therapy Designation for Syndax’s Revumenib to Treat Rare Leukemia
Read More
Load More
X